Why the study?
Does withdrawal of antihypertensive medication allow patients to remain normotensive in a general hypertensive population?
Does withdrawal of antihypertensive medication allow patients to remain normotensive in a general hypertensive population?
A significant proportion of hypertensive patients who meet blood pressure criteria may be able to successfully withdraw from antihypertensive therapy and remain normotensive for up to two years.
Answers are grounded in this paper and cite their sources.
May support withdrawal in selected patients meeting criteria; leaves open safety and generalizability without randomized trials.
To determine the fraction of all hypertensives who can be successfully withdrawn from antihypertensive medication, a study was conducted of a patient group originally drawn from a screened population of union members. Of 157 patients, 88 (56.1%) met preestablished blood pressure criteria for drug interruption, and 66 (75%) actually had medication withdrawn. Of these 66 patients, 69.8% and 54.5% followed up for one and two years, respectively, remained normotensive. Patients requiring reintroduction of antihypertensive therapy were distinguished from those remaining drug free by increased systolic blood pressure (141.4 +/- 13.2 vs 131.6 +/- 8.6 mm Hg) after one month. Extrapolation of the finding that 28% of the study population remained normotensive one year after drug therapy withdrawal suggests the possibility that as many as 5 million Americans currently taking antihypertensive drugs could have therapy interrupted for at least one year and thus avoid both the hazards and costs of drug therapy.
No takes yet. Share an insight, caveat, or question.
Michael H. Alderman (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: